TF
VRTX icon

Tompkins Financial’s Vertex Pharmaceuticals VRTX Stock Holding History

Tompkins Financial’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$12.5K Hold
24
– – ﹤0.01% 453
2026
Q2 		$11.9K Buy
+24
New +$10.6K ﹤0.01% 440
2024
Q3 		– Sell
-15
Closed -$7.03K – 622
2024
Q2 		$7.03K Hold
15
– – ﹤0.01% 504
2024
Q1 		$6.27K Hold
15
– – ﹤0.01% 537
2023
Q4 		$6.1K Hold
15
– – ﹤0.01% 532
2023
Q3 		$5.22K Hold
15
– – ﹤0.01% 507
2023
Q2 		$5.28K Hold
15
– – ﹤0.01% 514
2023
Q1 		$4.73K Hold
15
– – ﹤0.01% 539
2022
Q4 		$4K Buy
+15
New +$4.57K ﹤0.01% 548
2020
Q3 		– Sell
-50
Closed -$15K – 398
2020
Q2 		$15K Hold
50
– – ﹤0.01% 304
2020
Q1 		$12K Hold
50
– – ﹤0.01% 314
2019
Q4 		$11K Buy
+50
New +$10.1K ﹤0.01% 341
2014
Q3 		– Sell
-4
Closed – – 518
2014
Q2 		$0 Hold
4
– – ﹤0.01% 543
2014
Q1 		$0 Buy
+4
New +$317 ﹤0.01% 546

Other funds holding VRTX

MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GGS
Galvin Gaustad & Stein Scottsdale, Arizona $1.33B AUM 13.15% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
LJHT
Laurie J. Hall Trustee $314M AUM 27.43% 1-Year Est. Return
CFG
Cooper Financial Group Irvine, California $1.26B AUM 21.18% 1-Year Est. Return

Tompkins Financial's VRTX Position: Q3 2026 in Review

Tompkins Financial held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2026 at 24 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #453.

Tompkins Financial first reported a position in VRTX in Q1 2014 and has held it in 14 quarters since. The position peaked at $15K in Q2 2020. 66 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Tompkins Financial held 24 shares of Vertex Pharmaceuticals worth $12.5K as of Q3 2026.
  • Tompkins Financial left its Vertex Pharmaceuticals share count unchanged in Q3 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Tompkins Financial's portfolio in Q3 2026, its #453 holding.
  • Tompkins Financial first reported a position in Vertex Pharmaceuticals in Q1 2014 and has held it in 14 quarters since.
  • Tompkins Financial's Vertex Pharmaceuticals position peaked at $15K in Q2 2020.
  • 66 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Tompkins Financial's 13F filing for Q3 2026, filed 5 Oct 2026.